Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era

BACKGROUND: There is recognition that breast cancer is a collection of heterogeneous diseases divided in subtypes based on combined molecular features such as hormonal receptors (HR) and human epidermal growth factor receptor 2 (HER2) status. We aimed to study clinical differences among biological s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurooncol Pract
Autori principali: Bastos, Dhiego Chaves de Almeida, Maldaun, Marcos Vinicius Calfat, Sawaya, Raymond, Suki, Dima, Lang, Frederick F, Brown, Paul D, Rao, Ganesh, Weinberg, Jeffrey S, Prabhu, Sujit S
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6655427/
https://ncbi.nlm.nih.gov/pubmed/31386016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npx033
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi